Purpose

The purpose of this study is to compare outcomes of subjects undergoing multilevel lumbar fusion (MLF) surgery with and without the iFuse 3-D implants in the "bedrock" trajectory.

Conditions

Eligibility

Eligible Ages
Between 21 Years and 75 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Age 21-75 at time of screening 2. Patient scheduled for multilevel (>3 levels) spinal fusion surgery with planned fixation to the pelvis using S2AI screws 3. Patient has signed study-specific informed consent form 4. Patient has the necessary mental capacity to participate and is physically able to comply with study protocol requirements

Exclusion Criteria

  1. Indication for multilevel spine fusion surgery is any of the following: 1. Congenital neuromuscular disease 2. Prior pelvic fixation (i.e., patient already has S2AI or iliac bolts in place, current surgery indicated to revise this hardware) 3. Grade IV spondylolisthesis 2. Prior sacroiliac joint fusion/fixation on either side 3. Presence of spinal cord stimulator 4. Presence of severe hip pain that could impair functional and quality of life improvement from complex spine surgery 5. Surgeon plans to use iliac screw for pelvic fixation 6. Any known sacral or iliac pathology 7. Any condition or anatomy that makes treatment with the iFuse Implant System infeasible 8. Known metabolic bone disease 9. Severe osteoporosis 10. Known allergy to titanium or titanium alloys 11. Use of medications known to have detrimental effects on bone quality and soft-tissue healing 12. Neurologic condition that would interfere with postoperative physical therapy 13. Current local or systemic infection that raises the risk of surgery 14. Patient currently receiving or seeking short- or long-term worker's compensation and/or currently involved in injury litigation related to the SI joint or low back pain. 15. Currently pregnant or planning pregnancy in the next 2 years 16. Prisoner or a ward of the state. 17. Known or suspected drug or alcohol abuse 18. Uncontrolled psychiatric disease that could interfere with study participation 19. Fibromyalgia

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
Standard care
Multilevel Lumbar Fusion Surgery
  • Procedure: Multilevel Lumbar Fusion surgery
    Procedure in which 3 or more spinal segments are fused and concomitant pelvic fixation is performed.
Experimental
Standard Care + iFuse 3-D
Multilevel Lumbar Fusion Surgery with additional placement of iFuse 3-D in a trajectory parallel to the S2AI screws
  • Device: iFuse 3-D in Bedrock Configuration
    Procedure in which 3 or more spinal segments are fused and concomitant pelvic fixation is performed, additionally iFuse 3-D implants are placed in a trajectory parallel to the S2AI screws.
  • Procedure: Multilevel Lumbar Fusion surgery
    Procedure in which 3 or more spinal segments are fused and concomitant pelvic fixation is performed.

Recruiting Locations

More Details

NCT ID
NCT04062630
Status
Active, not recruiting
Sponsor
SI-BONE, Inc.

Detailed Description

This is a multicenter randomized controlled, postmarket clinical study to determine the differences between subjects undergoing standard MLF surgery with S2AI fixation in the pelvis vs the additional placement of iFuse 3-D in the bedrock configuration during MLF surgery. Subjects will be monitored for sacroiliac (SI) joint pain and at two years post surgery a CT scan will be taken to assess S2AI screw loosening or any other findings.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.